A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors | MicrobiomeTrials← Back to trialsNCT05538130
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2022-11-30Est. Completion: 2027-08-02
Enrollment target: 124 participants Locations- The Kirklin Clinic of UAB Hospital, Birmingham, Alabama, United States
- The University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of Alabama at Birmingham - Phase I Clinical Trials Unit, Birmingham, Alabama, United States
- Highlands Oncology Group, PA, Fayetteville, Arkansas, United States
- Highlands Oncology Group, PA, Rogers, Arkansas, United States
- Highlands Oncology Group, PA, Springdale, Arkansas, United States
- The Angeles Clinic and Research Institute- A Cedars-Sinai Affiliate, Los Angeles, California, United States
- Keck Hospital of USC, Los Angeles, California, United States
- Los Angeles General Medical Center, Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
- Keck Medical Center of USC Pasadena, Pasadena, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
- UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco, California, United States
- UCSF Medical Center, Investigational Pharmacy, San Francisco, California, United States
Other microbiome trials you might be interested in
MelanomaLi-Fraumeni SyndromePulmonary BlastomaChordomaCongenital Bone Marrow Failure SyndromesCostello SyndromeFanconi AnemiaCFC Syndrome (CFCS)Legius SyndromeRASopathies
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer…
Rockville, United StatesEst. completion Jan 1, 2035
Recurrent Melanoma (Skin)
The Angeles Clinic and Research Institue, A Cedars-Sinai Affiliate (Emergency Back-up only), Santa Monica, California, United StatesMoffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa, Florida, United StatesMoffitt Cancer Center, Tampa, Florida, United StatesMoffitt McKinley Hospital, Tampa, Florida, United StatesOchsner Clinic Foundation, New Orleans, Louisiana, United StatesMassachusetts General Hospital, Boston, Massachusetts, United StatesOphthalmic Consultants of Boston Inc (OCB), Boston, Massachusetts, United StatesBrigham and Women's Hospital, Boston, Massachusetts, United StatesDana-Farber Cancer Institute, Boston, Massachusetts, United StatesMass General Waltham, Waltham, Massachusetts, United StatesBrigitte Harris Cancer Pavilion, Detroit, Michigan, United StatesHenry Ford Hospital, Detroit, Michigan, United StatesHealthPartners Frauenshuh Cancer Center, Saint Louis Park, Minnesota, United StatesMethodist Hospital Inpatient Pharmacy, Saint Louis Park, Minnesota, United StatesHealthPartners Cancer Center at regions Hospital, Saint Paul, Minnesota, United StatesRegions Hospital Pharmacy, Saint Paul, Minnesota, United StatesMSK Basking Ridge., Basking Ridge, New Jersey, United StatesMSK Monmouth., Middletown, New Jersey, United StatesMSK Bergen., Montvale, New Jersey, United StatesOptum Medical Care, PC, Brewster, New York, United StatesMSK Commack., Commack, New York, United StatesMSK Westchester., Harrison, New York, United StatesOptum Medical Care, PC, Mount Kisco, New York, United StatesLaura & Isaac Perlmutter Cancer Center - NYU ACC, New York, New York, United StatesLaura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United StatesNYU Langone Faculty Group Practice, New York, New York, United StatesNYU Langone Medical Center (Tisch Hospital), New York, New York, United StatesMemorial Sloan Kettering Cancer Center 53rd street., New York, New York, United StatesColumbia University Irving Medical Center, New York, New York, United StatesColumbia University Medical Center - Neurological Institute of New York, New York, New York, United StatesCUIMC Research Pharmacy, New York, New York, United StatesMemorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United StatesMSK Nassau., Uniondale, New York, United StatesCleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland, Ohio, United StatesCleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United StatesProvidence Cancer Institute Franz Clinic, Portland, Oregon, United StatesProvidence Portland Medical Center, Portland, Oregon, United StatesUPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United StatesSCRI Oncology Partners, Nashville, Tennessee, United StatesUniversity of Texas MD Anderson Cancer Center, Houston, Texas, United StatesFred Hutchinson Cancer Center, Seattle, Washington, United StatesUniversity of Washington Medical Center, Seattle, Washington, United StatesUniversity of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United StatesUniversity of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United StatesPeter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaThe Alfred Hospital, Melbourne, Victoria, AustraliaRoyal Melbourne Hospital, Parkville, Victoria, AustraliaANIMI - Unidade de Tratamento Oncologico, Lages, Santa Catarina, BrazilCentro de Oncologia - CEON+ - Unidade São Caetano do Sul, São Caetano do Sul, BrazilIBCC - Núcleo de Pesquisa e Ensino, São Paulo, BrazilCross Cancer Institute, Edmonton, Alberta, CanadaAlberta Health Services and The Governors of The University of Alberta, Edmonton, Alberta, CanadaThe Ottawa Hospital - General Campus, Ottawa, Ontario, CanadaSunnybrook Research Institute, Toronto, Ontario, CanadaPrincess Margaret Cancer Centre, Toronto, Ontario, CanadaJewish General Hospital, Montreal, Quebec, CanadaMcGill University Health Centre, Montreal, Quebec, CanadaCentre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus, Québec, Quebec, CanadaFujian Cancer Hospital, Fuzhou, Fujian, ChinaZhejiang Cancer Hospital, Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaRabin Medical Center, Petah Tikva, Central District, IsraelSheba Medical Center, Ramat Gan, Central District, IsraelHadassah Medical Center, Jerusalem, Jerusalem, IsraelSoroka Medical Center, Beersheba, Southern District, IsraelSourasky Medical Center, Tel Aviv, TELL ABĪB, IsraelNational Cancer Center Hospital East, Kashiwa, Chiba, JapanKansai Medical University Hospital, Hirakata, Osaka, JapanMetastatic Melanoma
Melanoma Stage IV
Melanoma Stage III
In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therape…
Orange, United StatesEst. completion Dec 31, 2027
MelanomaNon Small Cell Lung CancerSolid TumorRare CancersHigh Grade Glioma
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis…
Scottsdale, United StatesEst. completion Dec 28, 2032